https://scholars.lib.ntu.edu.tw/handle/123456789/627095
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | YU-YUN SHAO | en_US |
dc.contributor.author | Hsu, Hung-Wei | en_US |
dc.contributor.author | Wo, Rita Robin | en_US |
dc.contributor.author | Wang, Han-Yu | en_US |
dc.contributor.author | ANN-LII CHENG | en_US |
dc.contributor.author | CHIH-HUNG HSU | en_US |
dc.date.accessioned | 2023-01-10T03:08:33Z | - |
dc.date.available | 2023-01-10T03:08:33Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 00302414 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/627095 | - |
dc.description.abstract | Composite cyclin-dependent kinase (CDK) inhibition has shown potential as a treatment for hepatocellular carcinoma (HCC) in preclinical studies. We tested whether the specific inhibition of CDK9 was effective against HCC. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Oncology | en_US |
dc.subject | Apoptosis; Cell line; Cyclin; Cyclin-dependent kinase 9; Hepatocellular carcinoma; Myeloid cell leukemia-1; Orthotopic model; Preclinical study; RNA polymerase; Xenograft | en_US |
dc.title | Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1159/000526978 | - |
dc.identifier.pmid | 36103810 | - |
dc.identifier.scopus | 2-s2.0-85143196356 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85143196356 | - |
dc.relation.journalvolume | 100 | en_US |
dc.relation.journalissue | 11 | en_US |
dc.relation.pageend | 611 | en_US |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Cancer Administration and Coordination Center | - |
crisitem.author.orcid | 0000-0001-7334-1912 | - |
crisitem.author.orcid | 0000-0002-9152-6512 | - |
crisitem.author.orcid | 0000-0003-0495-973X | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。